166 related articles for article (PubMed ID: 37032077)
41. Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images.
Cannella R; Borhani AA; Minervini MI; Tsung A; Furlan A
Abdom Radiol (NY); 2019 Apr; 44(4):1323-1330. PubMed ID: 30267107
[TBL] [Abstract][Full Text] [Related]
42. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
[TBL] [Abstract][Full Text] [Related]
43. [Focal nodular hyperplasia of liver: a clinicopathologic study of 238 patients].
Chen LL; Ji Y; Xu JF; Lu SH; Hou YY; Hou J; Sujie A; Zeng HY; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):17-22. PubMed ID: 21429353
[TBL] [Abstract][Full Text] [Related]
44. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
45. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma.
Park HJ; Byun JH; Kang JH; Kang HJ; Yu E; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
Eur J Radiol; 2021 Jun; 139():109730. PubMed ID: 33930719
[TBL] [Abstract][Full Text] [Related]
46. [57-year-old woman presenting with "nodules" of the liver].
Penna Ch
J Chir (Paris); 2002 Feb; 139(1):40-5. PubMed ID: 12071029
[No Abstract] [Full Text] [Related]
47. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
Alamri TM; Cerny M; Al Shaikh M; Billiard JS; Olivié D; Chagnon M; Tang A
Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
[TBL] [Abstract][Full Text] [Related]
48. Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.
Tselikas L; Pigneur F; Roux M; Baranes L; Costentin C; Roche V; Calderaro J; Herin E; Laurent A; Zafrani E; Azoulay D; Mallat A; Rahmouni A; Luciani A
Abdom Radiol (NY); 2017 Mar; 42(3):825-832. PubMed ID: 27704147
[TBL] [Abstract][Full Text] [Related]
49. [Incidental ultrasound finding of a 3 cm liver nodule in a 45-year-old woman taking hormonal substitution after hysterectomy performed for cervix carcinoma].
Guyader D; Latournerie M
Gastroenterol Clin Biol; 2009 Oct; 33(10-11 Suppl):F60-7. PubMed ID: 19766417
[TBL] [Abstract][Full Text] [Related]
50. Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report.
Bartley J; Loddenkemper C; Lange J; Mechsner S; Radke C; Neuhaus P; Ebert AD
Arch Gynecol Obstet; 2004 May; 269(4):290-3. PubMed ID: 15221322
[TBL] [Abstract][Full Text] [Related]
51. Focal nodular hyperplasia and hepatic adenoma: a review.
Lizardi-Cervera J; Cuéllar-Gamboa L; Motola-Kuba D
Ann Hepatol; 2006; 5(3):206-11. PubMed ID: 17060885
[TBL] [Abstract][Full Text] [Related]
52. Liver adenoma and focal nodular hyperplasia associated with oral contraceptives.
Tajada M; Nerín J; Ruiz MM; Sánchez-Dehesa M; Fabre E
Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):227-30. PubMed ID: 11848652
[TBL] [Abstract][Full Text] [Related]
53. [Highly differentiated hepatocellular tumors. Concepts, criteria, and differential diagnosis].
Schrimacher P; Prange W; Dries V; Dienes HP
Pathologe; 2001 Nov; 22(6):407-16. PubMed ID: 11766640
[TBL] [Abstract][Full Text] [Related]
54. Reply to "Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia".
Reizine E; Luciani A
J Magn Reson Imaging; 2020 Oct; 52(4):1279-1280. PubMed ID: 32022384
[TBL] [Abstract][Full Text] [Related]
55. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC
AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
[TBL] [Abstract][Full Text] [Related]
56. Diagnosis of focal nodular hyperplasia. Role of imaging techniques.
Soresi M; Carroccio A; Campagna P; Riili A; Vaglica S; Terranova A; Sesti R; Montalto G
Ann Ital Med Int; 2002; 17(2):95-101. PubMed ID: 12150051
[TBL] [Abstract][Full Text] [Related]
57. Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation.
Fujiwara H; Sekine S; Onaya H; Shimada K; Mikata R; Arai Y
Jpn J Radiol; 2011 Dec; 29(10):739-43. PubMed ID: 22009428
[TBL] [Abstract][Full Text] [Related]
58. Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy.
Kong CS; Appenzeller M; Ferrell LD
Acta Cytol; 2000; 44(2):218-22. PubMed ID: 10740609
[TBL] [Abstract][Full Text] [Related]
59. Hepatocellular adenoma and focal nodular hyperplasia: a series of 24 patients with clinicopathological and radiological correlation.
Ji Y; Zhu X; Sun H; Tan Y; Ma Z; Ye Q; Sujie A; Tang Z
Chin Med J (Engl); 2000 Sep; 113(9):852-7. PubMed ID: 11776086
[TBL] [Abstract][Full Text] [Related]
60. The Early-Enhancing Hepatic Vein: Differentiating Focal Nodular Hyperplasia and Hepatic Adenoma With Pathologic Validation in MRI.
Kania LM; Dave J; Guglielmo FF; Naringrekar HV; Alturki A; Civan JM; Bundschuh MA; Mitchell DG
J Magn Reson Imaging; 2023 Oct; 58(4):1191-1197. PubMed ID: 36744579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
